Sleep deprivation has quietly become one of the most pervasive public health issues of the modern era, impacting ...

A new daily pill, called Foundayo, is the second oral GLP-1 to reach the market in recent months, following the FDA approval ...

The FDA approval of Eli Lilly's GLP-1 pill Foundayo comes nearly three months after Novo Nordisk's oral version of Wegovy hit ...

FDA approved the Eli Lilly’s daily weight‑loss pill, a fast‑tracked GLP‑1 drug offering a new option for obesity treatment.

Eli Lilly's new weight-loss pill, sold under the name Foundayo, gives consumers a second option for a non-injectable GLP-1.

The US Food and Drug Administration on Wednesday approved the second GLP-1 pill for weight loss, adding another option to a ...

CR tested fish oil supplements from brands like CVS, GNC, and Nordic Naturals for heavy metals, rancidity, and label claims.

Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of ...

Lilly says Foundayo was approved to treat obesity and can lead to long-term weight loss, alongside diet and exercise.

Dr. David Kahana, a board-certified gastroenterologist and 1MD nutrition Scientific Medical Advisory board member; Dr. Erin ...

This innovative oral GLP-1 is a ‘small molecule’ medication that, unlike the Wegovy pill, doesn’t require that you take it on ...